Alpha Spread

Ares Commercial Real Estate Corporation
NYSE:ACRE

15.77 USD -0.05 USD ( -0.32% )

Ares Commercial Real Estate Corporation (NYSE:ACRE)

Add ACRE to Watchlist
Section:
 

Summary

Business Profile
Ares Commercial Real Estate Corporation

Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, mezzanine loans, real estate preferred equity investments, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York. [ Read More ]

Country

United States of America

Industry

REIT-Mortgage

Market Cap

741M USD

Enterprise Value

741M USD

Dividend Yield

9%

Buyback Yield

-27%

Investment Score
Ares Commercial Real Estate Corporation

49
Valuation
56
Profitability
-
Solvency
No Solvency Score Available

There isn't enough data to calculate the solvency score.

Intrinsic Valuation

ACRE Intrinsic Value
Intrinsic value based on company cash flows

The intrinsic value of one ACRE stock under the base scenario is 14.43 USD. Compared to the current market price of 15.77 USD, the company's shares are trading near their fair value.

Worst
Scenario
10.15 USD
Overvalued by 36%
Intrinsic Value
36%
Price
Base
Scenario
14.43 USD
Overvalued by 9%
Intrinsic Value
9%
Price
Best
Scenario
20.94 USD
Undervalued by 33%
Intrinsic Value
Price
33%

Analyst Rating

Analyst Price Target
ACRE Price Target

12 month price targets for ACRE stock made by Wall Street analysts. The average price target is 16.58 USD with a high forecast of 17.33 USD and a low forecast of 15.66 USD.

Lowest
Forecast
15.66 USD
Downside 1%
Average
Forecast
16.58 USD
Upside 5%
Highest
Forecast
17.33 USD
Upside 10%

Relative Valuation

P/S
Price to Sales

8.79

P/E
Price to Earnings

11.82

P/B
Price to Book Value

1.09

Price/Deposits
Price to Deposists

-

Competitors

Competitors Valuation Chart
Ares Commercial Real Estate Corporation Competitors

Competitors Valuation Table
Ares Commercial Real Estate Corporation Competitors

Shareholder Return

Stock Performance
ACRE Price Statistics

ACRE Market
1 Week +0% +1%
6 Months +10% +8%
1 Year +68% +31%
3 Years +41% +65%

Stock Price
ACRE Price Chart

1M
6M
1Y
3Y
5Y

Forecasted Financials

Revenue
Forecast of Future Revenue

-
-
-
-
-
-
-
-

Net Income
Forecast of Future Net Income

-
-
-
-
-
-
-
-

Ares Commercial Real Estate Corporation Revenue and Net Income forecasts made by Wall Street analysts.

ALPHA SPREAD

Company

About Us Pricing Contact Us Terms of Service Privacy Policy

Tools

Stock Screener Intrinsic Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks

© 2019-2021 www.alphaspread.com. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. In no event shall www.alphaspread.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.